17 years of Remidio! From preventing blindness and preserving vision to exploring systemic health through Oculomics AI, our journey continues to evolve.
Congratulations to Anand and the entire Remidio team. Here's to building further and moving ahead together!
#17YearsOfRemidio
At #RSSDI2026, Dr. Anand Sivaraman, Founder & CEO of Remidio, will speak on “One Scan, Three Organs”, exploring how Oculomics AI can extend retinal imaging to assess cardiovascular and kidney health risks.
#Oculomics#Remidio
Meet Remidio at #RSSDI2026 in Bengaluru! Explore InstaZ and Oculomics CVD & CKD AI at Stall R11. Connect with our team and discover how retinal imaging and AI can support screening for systemic health risks. #Oculomics#Remidio
Dr. Nishanth K. R., Associate Professor of Cardiology, shares his perspective on how retinal imaging and Oculomics AI could support community-based screening for cardiovascular and kidney disease risks.
#Oculomics#RSSDI2026#Remidio
Remidio wins the 2026 Anjani Mashelkar Foundation Prize, recognising our AI-enabled retinal imaging technology and its contribution to accessible, affordable eye screening. Presented to Dr. Anand Sivaraman on 17 November at Pune International Centre. #InclusiveInnovation#Remidio
Remidio’s ROP AI is featured in The Times of India! Jointly developed with KIDROP and funded by BIRAC, this offline solution is the WORLD’S FIRST REGULATORY-APPROVED AI FOR ROP SCREENING, helping flag suspected cases for specialist review.
#ROP#Remidio
This World Prematurity Day, Remidio highlights MediosHI ROP AI, the world’s first regulator-approved AI-based ROP screening solution, alongside Insta Neubo 130.
Combining wide-field imaging with offline AI-assisted triage, it supports timely specialist review and referral.
Remidio at #EgSCRS2026 in Cairo! Swati Bhattacharya and Shashank Pai connected with Hend El-Kadi, Valerie Saw, Faisal Ahmed, Resitha Airey and Yehia Salaheldin Mostafa, exchanging perspectives on ophthalmic care and clinical practice.
#Ophthalmology#Remidio
Good health deserves attention at every age. This World Diabetes Day and Children’s Day, let’s build awareness and encourage everyday choices for healthier beginnings and brighter tomorrows.
#WorldDiabetesDay#ChildrensDay#Remidio
Screen the Eye. Protect Heart & Kidneys.
Remidio’s Oculomics AI uses retinal images to generate a single risk score for systemic health risks, supporting non-invasive screening.
Meet us at RSSDI 2026, Bengaluru, on 19 November at Stall R11.
#Oculomics#RSSDI2026#Remidio
Dr. Anand Sivaraman, Founder & CEO of Remidio, will join Panel 01 at the Maharashtra Impact & Innovation Hub Forum 2026 to discuss translating MedTech innovation into real-world clinical impact.
📅 November 13 | IIT Bombay, Mumbai
#MedTech#Remidio
Remidio at #OSOCON2026! Explore InstaEyeClinic and Pristine 5.0, designed for ophthalmic examination and retinal imaging. We look forward to connecting with ophthalmologists and eye care professionals across Odisha.
#Ophthalmology#EyeCare#Remidio
Keratoconus can gradually affect corneal shape and vision. Early detection helps clinicians plan timely management and protect patients’ quality of life.
This World Keratoconus Day, raising awareness with InstaKC.
#WorldKeratoconusDay#Remidio
Remidio at #EGSCRS2026!
Explore InstaZ, Insta Neubo 130 and InstaEyeClinic, designed to support ophthalmic imaging and clinical practice.
We look forward to connecting with ophthalmologists, eye care professionals and industry partners.
#Ophthalmology#EyeCare
May this Diwali bring light, hope and brighter days. Let’s also care for our eye health and cherish the gift of sight that helps us enjoy life’s special moments.
Wishing everyone a happy, safe and healthy Diwali!
#HappyDiwali#Remidio#EyeHealth
Anusha Purushotham, VP – Policy & Strategic Partnerships at Remidio, will share her perspective on AI readiness and responsible AI adoption in healthcare at PATH's AI Readiness Framework Convening.
📅 November 4 | 📍 New Delhi
#AIinHealthcare#DigitalHealth#Remidio
What if your fundus image could reveal more about health than meets the eye?
Remidio is exploring AI-powered retinal screening and its potential beyond eye health.
Something new is coming at #RSSDI2026. Stay tuned.
#Oculomics#Remidio
Remidio at the 6th APOIS Congress, Seoul.
Dr. Divya Rao presented on moving oculomics research into clinical practice, as the team explored AI’s role in understanding health beyond the eye.
#APOIS2026#Oculomics#Remidio
Happy Karnataka Rajyotsava!
May Karnataka’s rich culture, beautiful language and glorious heritage inspire us to bring the gift of better vision to more people.
ನಾಡು, ನುಡಿ, ಸಂಸ್ಕೃತಿಗೆ ನಮ್ಮ ನಮನ!
#KarnatakaRajyotsava#Karnataka#Remidio